Study on transfer of cefuroxime axetil, a new cephalosporin antibiotic, in infected model in rabbits. Transfer into soft tissues of oral and maxillofacial region.:—Transfer into soft tissues of oral and maxillofacial region—
スポンサーリンク
概要
- 論文の詳細を見る
In the application of a drug to clinical use, it is essential to define its pharmacokinetics. Usually, a pharmacokinetic study is performed in healthy animals in the stage of <I>in vivo</I> studies. In the case of antibiotics, however, it is desirable to study the transfer of the drug using an infected model. We prepared an experimental infected model in rabbits using the Satoh and Heimdahl method which we had used for several years, and orally administrered to these rabbits cefuroxime axetil : CXM-AX, a new cephalosporin antibiotic, to study tissue transfer of the drug in them with that in healthy rabbits. In this study, transfer especially into soft tissues or the oral and maxillofacial region : tongue, gingiva, submandibular gland, parotid gland and submandibular lymphonodi, and into serum were examined, and use of the drug to tissues with dental infections and subsequent symptoms was discussed.<BR>Results<BR>1) In the infected animal group, peaks of the drug levels in the examined tissues were attained 4-42 minutes later than that of serum level, and the peak levels in tissues were about 43-88% of that in serum. Pus level got to the peak 23 minutes later than serum level, and the peak level in pus was about 31% of that in serum. In the healthy animal group, peaks of the drug levels in various tissues appeared 4-18 minutes after that of serum level, and peak levels in tissues were about 27-71% of that in serum. High concentrations of CXM were noted in the gingiva and the submandibular gland, both in the infected and in the healthy animal group.<BR>2) CXM levels in tissues and serum were obout 1.2-2 times higher in the infected animal group than in the healthy animal group.<BR>3) Comparatively good transfer of CXM into pus was observed in experimental lesion, althogh it was not as good as that into serum, and T1/2 was long. The above results demonstrated <I>in vivo</I> that CXM-AX exerts satisfactory effects at the lesion for inflammatory disorders.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果